Hair :: Wool research may help human hair disorder
Sheep gene research at the University of Adelaide’s Roseworthy Campus aimed at helping maximise wool production for Australian producers, has shed light on a human genetic hair and skin disorder.
Food
Blood :: Transfusion expert urges wider use of filtered blood
Filtering white cells from donor blood before a transfusion is much safer for patients and long overdue as a national standard for all surgical procedures, according to University of Rochester researchers who present their analysis in the April journal, Transfusion.
E Coli :: Souplantation works to Identify E coli contamination at Foothill Ranch Restaurant
Souplantation announced it is cooperating with the Orange County Health Care Agency in an investigation of a confirmed E.coli outbreak at its Foothill Ranch restaurant located at 26572 Towne Center Drive, Lake Forest, CA 92610.
Irritable Bowel Syndrome :: Novartis suspends US marketing and sales of Zelnorm
Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation.
Hepatitis :: FDA approves GSK’s Twinrix Vaccine Schedule for Hepatitis A and Hepatitis B
GlaxoSmithKline [NYSE:GSK] announced that the U.S. Food and Drug Administration (FDA) has approved Twinrix? [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months.
Depression :: Fewer children and teens received antidepressants following FDA warnings
The number of children and teenagers prescribed antidepressant medications appears to have decreased following public warnings about suicidal behavior potentially associated with the drugs, according to a report published in the April issue of Archives of General Psychiatry, one of the JAMA/Archives journals. In addition, antidepressants are now more often prescribed to this age group by psychiatrists rather than primary care physicians.
Diabetes :: FDA Approves Janumet for Type 2 Diabetes
Janumet (sitagliptin/metformin HCl) provides significantly greater A1C1 reduction than metformin alone and helped more than twice as many patients get to A1C goal.
Sleep Apnea :: Cephalon’s Nuvigil approved for sleep apnea, sleep disorders
Cephalon, Inc. (Nasdaq: CEPH) announced that it has received an approvable letter, together with draft labeling, from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA) for NUVIGIL(TM) (armodafinil) Tablets [C-IV] for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS) and shift work sleep disorder (SWSD).
Pet :: Hill’s Pet Nutrition’s pet food products contain melamine
The Food and Drug Administration (FDA) notified Hill’s Pet Nutrition, Inc., of Topeka, Kansas, that FDA testing has detected melamine and melamine byproducts in wheat gluten received by the company to make dry cat food.
Health :: International health security issues – World Health Day 2007
A WHO background document will be used to help guide discussions and stir debate. The paper profiles eight issues linked to international health security, together with key points to focus the debate: